FKBP5 and ischemic stroke: This strategy preserves normal synaptic transmission and minimizes global neurological side effects, positioning FKBP51 modulation as a safer and more specific therapeutic approach that circumvents the pitfalls of direct NMDAR inhibition in ischemic stroke.